Smith & Nephew (Smith & Nephew) Days Inventory

: 490.55 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

Days Inventory is also known as Days Sales of Inventory (DSI). Smith & Nephew's Average Total Inventories for the six months ended in Dec. 2023 was $2,403 Mil. Smith & Nephew's Cost of Goods Sold for the six months ended in Dec. 2023 was $894 Mil. Hence, Smith & Nephew's Days Inventory for the six months ended in Dec. 2023 was 490.55.

The historical rank and industry rank for Smith & Nephew's Days Inventory or its related term are showing as below:

SNN' s Days Inventory Range Over the Past 10 Years
Min: 324.1 Med: 401 Max: 498.97
Current: 498.97

During the past 13 years, Smith & Nephew's highest Days Inventory was 498.97. The lowest was 324.10. And the median was 401.00.

SNN's Days Inventory is ranked worse than
87.61% of 775 companies
in the Medical Devices & Instruments industry
Industry Median: 186.73 vs SNN: 498.97

Smith & Nephew's Days Inventory declined from Dec. 2022 (499.08) to Dec. 2023 (490.55).

Inventory Turnover measures how fast the company turns over its inventory within a year. Smith & Nephew's Inventory Turnover for the six months ended in Dec. 2023 was 0.37.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Smith & Nephew's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.85.

Smith & Nephew Days Inventory Historical Data

The historical data trend for Smith & Nephew's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

410.42

432.06

418.11

479.83

485.26

Smith & Nephew Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															444.98	452.59	499.08	503.84	490.55

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew Days Inventory Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Days Inventory distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Days Inventory falls into.

Smith & Nephew Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Smith & Nephew's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2205	+	2395)	/	2 )	/	1730	*	365
=	2300					/	1730	*	365
=	485.26

Smith & Nephew's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (2411	+	2395)	/	2 )	/	894	*	365 / 2
=	2403					/	894	*	365 / 2
=	490.55

Smith & Nephew (NYSE:SNN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Smith & Nephew's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	894	/	2403
	=	0.37

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Smith & Nephew's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2403	/	2815
	=	0.85

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Smith & Nephew Days Inventory Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.